Clinical Trial: SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895992) titled 'SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study' on Oct. 19.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR-A2009 combined bevacizumab versus Sacituzumab Tirumotecan in the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Non-squamous Non-small Cell Lung Cancer

Intervention: DRUG: SHR-A2009 + bevacizumab

SHR-A2009 + bevacizumab

DRUG: Sacituzumab Tiru...